National Institute of Medical Research Muheza

Facility Details

Region
East Africa

GLP Lead
IVCC

GLP Compliance Progress

Status 1. Site Development

GLP Compliance Target 2020 Q2

Product Testing

IRS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

LLINS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

SPACE SPRAYS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

LARVICIDES

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

TOPICAL REPELLENTS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

GENETICALLY MODIFIED MOSQUITOES

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

Capacity and Features

Number of huts
13

Style of Huts
East African & West African

Any Other Facilities
Mosquito-spheres; platforms; animal houses; insectary.

Laboratory Strains
- Strain Names & Species

An. gambiae Kisumu;
An. gambiae Zenet;
Cx. quinquefasciatus Masimbani.

Wild Populations (and Resistance Profiles) - Species

An. gambiae sl.;
An. funestus sl.;
Cx. Quinquefasciatus;
Ae. Aegypti.

Hut testing possible in the following months of the year

  • april
  • may
  • june
  • july
  • october
  • november
  • december

Village Scale Trials possible in the following months of the year

  • ht-april
  • ht-may
  • ht-june
  • ht-july
  • ht-october
  • ht-november
  • ht-december

Contact Details

Contact
William N. Kisinza

Phone Number
 +255754362777 / +255 27 2977612

Email Address
wnkisinza@gmail.com
wkisinza@nimr.or.tz

Website
http://www.nimr.or.tz